Safety of elobixibat and lubiprostone in Japanese patients with chronic constipation: a retrospective cohort study.

No new safety concerns have been raised in relation to elobixibat and lubiprostone use for treating chronic constipation, although the HR of different events varied. Further larger-scale study is needed as the estimates for events of small numbers were unstable.